The closing of the transaction is subject to receipt of applicable regulatory approvals in China
Drug major Cipla said its Mauritius subsidiary Meditab Holdings has signed a deal to sell its entire 48.22 per cent stake in China-based Jiangsu Cdymax Pharmaceuticals for $ 18.5 million (over Rs 114 crore).
” Meditab Holdings, Mauritius, a wholly-owned subsidiary of the company, has entered into a definitive agreement to sell its entire 48.22 per cent equity interest in Jiangsu Cdymax Pharmaceuticals Co, China to an affiliate of one of the other shareholders of Jiangsu, for a total consideration of $ 18.5 million,” Cipla said in a filing to the BSE.
According to a report in PTI, the closing of the transaction is subject to receipt of applicable regulatory approvals in China, it added.
EP News Bureau – Mumbai